[Myelosuppression due to antineoplastic agents].
Shigeoka
Yasushi
Y
Division of Medical Oncology and Molecular Respirology, Faculty of Medicine, Tottori University.
Shimizu
Eiji
E
D000740:Anemia / Q000139:chemically induced*; D000900:Anti-Bacterial Agents / Q000627:therapeutic use; D000970:Antineoplastic Agents / Q000009:adverse effects*; D005334:Fever / Q000139:chemically induced* / Q000188:drug therapy; D016179:Granulocyte Colony-Stimulating Factor / Q000627:therapeutic use; D006801:Humans; D009503:Neutropenia / Q000139:chemically induced* / Q000188:drug therapy; D012307:Risk Factors; D013921:Thrombocytopenia / Q000139:chemically induced*
D000900:Anti-Bacterial Agents; D000970:Antineoplastic Agents; D016179:Granulocyte Colony-Stimulating Factor